It is not currently available as a licensed medicine in the UK
We developed The Caremark Guide: Transforming Metabolic Health to be a comprehensive reference for payors who want to provide coverage for clinically appropriate metabolic health therapies in a way that makes sense for their business
Its cell-penetrating properties allow it to enter cells without transfection or vector delivery, where it directly engages the p53 TAD2 domain to disrupt the FOXO4-p53 complex
GLP-1 analogues have a unique property whereby it reduces neuroinflammation, reduces tau formation, reduces insulin resistance, reduces amyloid formation, and improves connection between the brain cells. Paul Edison, MD, PhD Edison and his team believe liraglutides brain protection may stem from causing a slower loss of brain volume
Nausea from GLP-1 agonists typically peaks 1 to 3 hours after injection
By utilizing lower doses, GLP-1 microdosing minimizes the likelihood of adverse side effects, making it a safer and more sustainable option for preventive care